1. Home
  2. LCII vs BEAM Comparison

LCII vs BEAM Comparison

Compare LCII & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LCII

LCI Industries

HOLD

Current Price

$126.76

Market Cap

3.0B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$29.15

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCII
BEAM
Founded
1956
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LCII
BEAM
Price
$126.76
$29.15
Analyst Decision
Hold
Strong Buy
Analyst Count
5
12
Target Price
$102.40
$48.09
AVG Volume (30 Days)
230.4K
1.4M
Earning Date
02-10-2026
02-24-2026
Dividend Yield
3.64%
N/A
EPS Growth
38.80
N/A
EPS
7.12
N/A
Revenue
$3,992,455,000.00
$55,701,000.00
Revenue This Year
$10.93
N/A
Revenue Next Year
$4.29
$26.52
P/E Ratio
$17.75
N/A
Revenue Growth
5.74
N/A
52 Week Low
$72.31
$13.53
52 Week High
$126.56
$35.25

Technical Indicators

Market Signals
Indicator
LCII
BEAM
Relative Strength Index (RSI) 73.52 63.38
Support Level $122.53 $26.25
Resistance Level $125.00 $30.50
Average True Range (ATR) 2.45 1.49
MACD -0.24 -0.00
Stochastic Oscillator 95.59 68.91

Price Performance

Historical Comparison
LCII
BEAM

About LCII LCI Industries

LCI Industries Inc supplies domestically and internationally components for the original equipment manufacturers of recreational vehicles and adjacent industries including buses; and trailers used to haul boats, livestock, equipment, and other cargo. It has two reportable segments; the original equipment manufacturers segment and the aftermarket segment. The OEM Segment manufactures or distributes components for the OEMs of RVs and adjacent industries, including buses; trailers used to haul boats, livestock, equipment, and other cargo; trucks; pontoon boats; trains; manufactured homes; and modular housing. Its products are sold to manufacturers of RVs such as Thor Industries, Forest River, Winnebago, and other RV OEMs, and to manufacturers in adjacent industries.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: